Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels
Authors:
Open Access
- 3 August 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 103 (5) , 1811-1820
Abstract
In the present study, we examined the possible effect of chronic treatment with glucocorticoids on the morphology of the rat brain and levels of endogenous agmatine and arginine decarboxylase (ADC) protein, the enzyme essential for agmatine synthesis. Seven‐day treatment with dexamethasone, at a dose (10 and 50 μg/kg/day) associated to stress effects contributed by glucocorticoids, did not result in obvious morphologic changes in the medial prefrontal cortex and hippocampus, as measured by immunocytochemical staining with β‐tubulin III. However, 21‐day treatment (50 μg/kg/day) produced noticeable structural changes such as the diminution and disarrangement of dendrites and neurons in these areas. Simultaneous treatment with agmatine (50 mg/kg/day) prevented these morphological changes. Further measurement with HPLC showed that endogenous agmatine levels in the prefrontal cortex and hippocampus were significantly increased after 7‐day treatments with dexamethasone in a dose‐dependent manner. On the contrary, 21‐day treatment with glucocorticoids robustly reduced agmatine levels in these regions. The treatment‐caused biphasic alterations of endogenous agmatine levels were also seen in the striatum and hypothalamus. Interestingly, treatment with glucocorticoids resulted in a similar change of ADC protein levels in most brain areas to endogenous agmatine levels: an increase after 7‐day treatment versus a reduction after 21‐day treatment. These results demonstrated that agmatine has neuroprotective effects against structural alterations caused by glucocorticoids in vivo. The parallel alterations in the endogenous agmatine levels and ADC expression in the brain after treatment with glucocorticoids indicate the possible regulatory effect of these stress hormones on the synthesis and metabolism of agmatine in vivo.Keywords
This publication has 44 references indexed in Scilit:
- Expression of arginine decarboxylase in brain regions and neuronal cellsJournal of Neurochemistry, 2006
- Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neuronsNeuroscience, 2006
- Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stressExperimental Neurology, 2005
- Is agmatine a novel neurotransmitter in brain?Trends in Pharmacological Sciences, 2000
- Agmatine treatment is neuroprotective in rodent brain injury modelsLife Sciences, 1995
- Agmatine Is Widely and Unequally Distributed in Rat OrgansAnnals of the New York Academy of Sciences, 1995
- Phenytoin prevents stress‐ and corticosterone‐induced atrophy of CA3 pyramidal neuronsHippocampus, 1992
- Rat melanin-concentrating hormone messenger ribonucleic acid expression: marked changes during development and after stress and glucocorticoid stimuliEndocrinology, 1992
- Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. HippocampusDevelopmental Brain Research, 1990
- POLYAMINESAnnual Review of Biochemistry, 1984